11 February, 2026 in Uncategorized Pantherna Therapeutics supports the translational research at HHU and UKD Düsseldorf to advance non-viral nucleic acid delivery technologies for catalytic DNAzymes
08 January, 2026 in Uncategorized Kither Biotech and Pantherna Therapeutics Announce Strategic Collaboration on Synergistic mRNA and Peptide Therapies for Genetic Lung Diseases
29 October, 2025 in Uncategorized Pantherna Therapeutics Secures New Patent Grant in the United States of America
16 October, 2025 in Uncategorized Pantherna Therapeutics GmbH and ARCALIS, Inc. enter research collaboration to expand novel LNP solutions for future mRNA therapeutics
01 September, 2025 in Uncategorized Loma Therapeutics and Pantherna Therapeutics are pleased to announce a new collaboration aimed at accelerating the development of next-generation immunotherapies.
03 July, 2025 in Uncategorized Pantherna Therapeutics Further Expands Global IP Portfolio with New Patent Grant in Canada
04 June, 2025 in Uncategorized Pantherna Therapeutics Expands IP Portfolio with New Patent Grant in South Korea
16 April, 2025 in Uncategorized Pantherna Therapeutics Secures Japanese Patent for PTXmRNA® Technology
25 October, 2024 in Uncategorized Pantherna Therapeutics and TQ Therapeutics announce research collaboration to advance ultra-short Cell and Gene Therapy (CGT) process leveraging LNP technology
26 September, 2024 in Uncategorized Pantherna Announces Research collaboration with Bayer to Advance LNP Technology for Beyond Liver mRNA Therapy
